Research Peptide Terminology Glossary: 50 Terms Every New Researcher Should Know

# Research Peptide Terminology Glossary: 50 Terms Every New Researcher Should Know

> Disclaimer: This glossary is for educational purposes only. Research peptides are for laboratory use only and are not approved for human consumption.

When you first enter the world of research peptides, the terminology can feel like a foreign language. Researchers throw around terms like "lyophilized," "half-life," "subcutaneous," and "secretagogue" as if everyone knows what they mean. This glossary gives you the vocabulary you need to read research papers, evaluate vendor information, and communicate clearly with other researchers.

We have organized the 50 terms into logical groups so you can build understanding progressively.

---

Section 1: Basic Chemistry & Biochemistry

1. Amino Acid

The fundamental building block of peptides and proteins. There are 20 standard amino acids used in biology, each with a unique side chain that gives it distinct chemical properties. Examples: glycine (simplest), tryptophan (largest), cysteine (forms disulfide bonds).

2. Peptide

A molecule consisting of two or more amino acids linked by peptide bonds. Peptides are generally considered to be shorter than 50 amino acids; longer chains are called proteins. The term "oligopeptide" refers to short chains (typically 2-20 amino acids).

3. Peptide Bond

The covalent chemical bond that links amino acids together in a chain. Formed by a condensation reaction between the carboxyl group (-COOH) of one amino acid and the amino group (-NH2) of the next, releasing water.

4. Protein

A long polypeptide chain (typically 50+ amino acids) that has folded into a specific three-dimensional structure. Proteins perform virtually every function in living cells — enzymes, structural proteins, transport proteins, and signaling molecules.

5. Sequence

The specific order of amino acids in a peptide or protein, written from N-terminus (amino end) to C-terminus (carboxyl end). A peptide sequence is its identity — change one amino acid and you may change its function dramatically.

6. N-terminus and C-terminus

The two ends of a peptide chain. The N-terminus has a free amino group (-NH2); the C-terminus has a free carboxyl group (-COOH). Many peptides are described by modifications at these ends (e.g., "C-terminally amidated").

7. Molecular Weight (MW)

The mass of a molecule, typically expressed in Daltons (Da) or kiloDaltons (kDa). For peptides, MW is important for understanding how the molecule behaves in the body — larger peptides are broken down differently than smaller ones and may have different stability profiles.

8. Disulfide Bond

A covalent bond between two cysteine amino acids. These bonds stabilize the three-dimensional structure of some peptides and proteins. Many peptides with disulfide bonds have more complex synthesis requirements.

9. Hydrophilicity / Hydrophobicity

Whether a peptide is "water-loving" (hydrophilic) or "water-fearing" (hydrophobic). Hydrophilic peptides dissolve readily in water. Hydrophobic peptides may require different reconstitution approaches (e.g., adding a small amount of acetic acid or DMSO before adding water).

10. Isoelectric Point (pI)

The pH at which a peptide carries no net electrical charge. Understanding pI helps predict how a peptide will behave in solution and can guide reconstitution strategies.

---

Section 2: Pharmacology & Mechanism of Action

11. Receptor

A protein on or inside a cell that binds to a specific signaling molecule (like a peptide) and triggers a cellular response. Receptors are the "locks" that peptides (the "keys") interact with.

12. Agonist

A molecule that binds to a receptor and activates it, producing a biological response. Most research peptides are agonists — they mimic or enhance the action of naturally occurring molecules.

13. Antagonist

A molecule that binds to a receptor but does not activate it, instead blocking the receptor from being activated by agonists. Some research peptides are studied as antagonists to understand receptor biology.

14. Ligand

Any molecule that binds to a receptor, including both agonists and antagonists. "Ligand" is a general term that does not imply activation or inhibition.

15. Affinity

How tightly a peptide binds to its receptor. Higher affinity means the peptide binds at lower concentrations and stays bound longer. Expressed as the dissociation constant (Kd) — lower Kd = higher affinity.

16. Selectivity

How specifically a peptide interacts with its intended receptor versus other receptors. A highly selective peptide produces cleaner effects; a non-selective one may have broader (and potentially unwanted) effects.

17. Signal Transduction

The process by which a receptor converts extracellular signals (like peptide binding) into intracellular responses. Involves cascades of protein interactions, second messengers (like cAMP), and eventually changes in gene expression or cellular function.

18. Second Messenger

Intracellular molecules (like cAMP, cGMP, IP3, or calcium ions) that carry the signal from the receptor deeper into the cell. When a peptide activates a G-protein coupled receptor (GPCR), it often triggers production of a second messenger.

19. G-Protein Coupled Receptor (GPCR)

One of the largest and most important receptor families in biology. Many peptide receptors — including growth hormone secretagogue receptors and GLP-1 receptors — are GPCRs. They couple to G-proteins to generate intracellular second messengers.

20. Bioavailability

The fraction of an administered dose that reaches systemic circulation in an active form. Most peptides have poor oral bioavailability because they are broken down in the digestive tract. This is why many research peptides are administered subcutaneously or intramuscularly rather than orally.

---

Section 3: Pharmacokinetics

21. Half-Life

The time it takes for the concentration of a peptide in the body to be reduced by half. A peptide with a 30-minute half-life will have half its initial concentration after 30 minutes, a quarter after 60 minutes, etc. Half-life determines dosing frequency.

22. Clearance

The rate at which a peptide is removed from the body, usually by enzymatic breakdown (proteolysis) or renal filtration. Peptides with high clearance rates have short half-lives.

23. Volume of Distribution (Vd)

A theoretical measure of how widely a drug distributes throughout the body relative to its plasma concentration. A high Vd suggests the peptide distributes extensively into tissues.

24. Plasma Protein Binding

Many peptides bind to proteins in the blood (like albumin), which affects their availability for receptor binding and their half-life. Protein-bound peptides are inactive but serve as a reservoir.

25. Proteolysis

The enzymatic breakdown of peptides by proteases (enzymes that cut peptide bonds). Most peptides are degraded rapidly by proteases in the blood, liver, or gut. Resistance to proteolysis is a key design goal for long-acting research peptides.

26. AUC (Area Under the Curve)

A pharmacokinetic measurement representing total drug exposure over time. A higher AUC means more total exposure. Important when comparing how different formulations or routes of administration affect peptide exposure.

27. Cmax

The peak concentration of a peptide reached in plasma following administration. Relevant for understanding how much of the peptide is in circulation at its highest point.

28. Tmax

The time to reach Cmax. A longer Tmax suggests slower absorption.

---

Section 4: Formulation & Administration

29. Lyophilization

Freeze-drying. The process of removing water from a peptide solution by first freezing it and then reducing the surrounding pressure, allowing the ice to sublimate (convert directly from solid to gas) without passing through a liquid phase. The result is a stable, dry peptide powder that can be stored long-term.

30. Lyophilized Peptide

A peptide that has been freeze-dried into a powder for stability. Most research peptides are sold in this form. Before use in experiments, they must be reconstituted with a sterile solvent.

31. Reconstitution

The process of dissolving a lyophilized peptide in a solvent to create a usable solution. The solvent choice (typically Bacteriostatic Water) and the reconstitution procedure affect peptide stability.

32. Bacteriostatic Water (BAC Water)

Sterile water containing 0.9% benzyl alcohol, which prevents bacterial growth. The standard reconstitution solvent for most research peptides. The benzyl alcohol preservative extends the usable life of the reconstituted solution.

33. Sterile Water for Injection (SWFI)

Pure sterile water without preservatives. Can be used for reconstitution but the resulting solution has a much shorter shelf life than BAC water reconstituted peptides (use within 24 hours).

34. Acetic Acid Solution

Some hydrophobic peptides (like Melanotan II or IGF-1) do not dissolve readily in water alone. A dilute acetic acid solution (0.1-1%) is often used first to dissolve the peptide before diluting with BAC water.

35. Subcutaneous (SubQ)

Administration of a substance into the fatty tissue just below the skin. Most peptide research in animal models uses subcutaneous injection for consistent, reproducible absorption.

36. Intramuscular (IM)

Administration directly into muscle tissue. Produces faster absorption than subcutaneous injection but requires longer needles.

37. Intravenous (IV)

Administration directly into a vein. Produces immediate 100% bioavailability. Used in some research settings for precise dose-response studies.

38. Intranasal

Administration through the nasal passages. Some peptides (like Semax and Selank) are administered intranasally because the nasal mucosa provides direct access to the CNS via the olfactory pathway.

39. Vial

The glass or plastic container in which lyophilized research peptides are typically packaged. Usually sealed with a rubber stopper and aluminum crimp cap for sterility. Common sizes: 2 mL, 5 mL, 10 mL.

40. Certificate of Analysis (CoA)

A document from a testing laboratory confirming the identity, purity, and concentration of a peptide product. A valid CoA should come from an independent third-party laboratory and include HPLC purity data and mass spectrometry confirmation.

---

Section 5: Peptide Classes & Key Terms

41. Secretagogue

Any substance that stimulates secretion of a hormone or other molecule. Growth hormone secretagogues (GHSs) stimulate GH release from the pituitary. The term comes from the Latin "secreto" (to secrete) and Greek "agogos" (leading).

42. GHRP (Growth Hormone-Releasing Peptide)

A class of synthetic peptides that stimulate growth hormone release by binding to the ghrelin receptor (GHSR-1a). Examples: GHRP-2, GHRP-6, Hexarelin, Ipamorelin.

43. GHRH (Growth Hormone-Releasing Hormone)

A naturally occurring hypothalamic hormone that stimulates GH secretion from the pituitary. Synthetic analogues like CJC-1295 and Sermorelin mimic GHRH.

44. GLP-1 (Glucagon-Like Peptide-1)

An incretin hormone produced in the gut in response to food intake. Stimulates insulin secretion, inhibits glucagon, slows gastric emptying, and reduces appetite. Synthetic GLP-1 receptor agonists (Semaglutide, Liraglutide) are the basis of major metabolic disease therapies.

45. BPC-157 (Body Protection Compound-157)

A synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in gastric juice. Extensively studied in animal models for tissue repair, gut healing, and tendon recovery. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

46. IGF-1 (Insulin-Like Growth Factor 1)

A hormone primarily produced by the liver in response to growth hormone signaling. Mediates many of the anabolic effects of GH. Research peptides like IGF-1 LR3 (a long-acting variant) are used to study muscle and tissue growth.

47. Melanocortin

A class of peptides derived from POMC (pro-opiomelanocortin) that act on melanocortin receptors. Includes alpha-MSH (melanocyte-stimulating hormone). Synthetic variants like Melanotan I and II are studied for effects on pigmentation, sexual function, and appetite.

48. Purity

Expressed as a percentage, purity indicates what fraction of the peptide product is actually the intended peptide versus impurities (truncated sequences, oxidized products, salt counterions, etc.). Pharmaceutical-grade research peptides typically have greater than 98% purity by HPLC.

49. HPLC (High-Performance Liquid Chromatography)

The analytical technique most commonly used to verify peptide purity. Separates mixture components based on their affinity for the mobile phase versus a stationary phase. An HPLC chromatogram shows purity as the percentage of the total peak area that corresponds to the target peptide.

50. Mass Spectrometry (MS)

An analytical technique that identifies molecules by measuring their mass-to-charge ratio. Used to confirm peptide identity and detect impurities. Combined with HPLC (LC-MS), it provides both purity and identity confirmation — the gold standard for peptide quality verification.

---

Quick Reference: Units and Measurements

Common concentration math:

• •If you have 5 mg peptide in 2.5 mL BAC water = 2 mg/mL = 2,000 mcg/mL
• •A 200 mcg dose from a 2 mg/mL solution = 0.1 mL = 10 units on a 100-unit insulin syringe

Peptides.SO has a free reconstitution calculator at /tools/calculator to simplify these calculations.

---

Frequently Asked Questions

Q: What does "research grade" mean vs. "pharmaceutical grade"?

A: Research grade typically means the peptide is synthesized for non-clinical research use, while pharmaceutical grade meets stricter regulatory standards (GMP manufacturing, additional testing, tighter specifications). For most research applications, high-purity (98%+) research-grade peptides are sufficient.

Q: What does it mean when a peptide is described as "acetate salt"?

A: Most synthetic peptides are produced as salts — the peptide pairs with a counter-ion like acetate (CH3COO-) or trifluoroacetate (TFA). The salt form affects weight (a peptide listed as 5 mg acetate salt contains slightly less actual peptide), solubility, and sometimes stability. Acetate is preferred over TFA for biological research because TFA can have cytotoxic effects at high concentrations.

Q: What is the difference between a peptide and a small molecule drug?

A: Small molecule drugs are typically organic compounds with molecular weights below 500 Da. Peptides are larger and more structurally complex. Small molecules are usually orally bioavailable; peptides typically are not. However, peptides offer greater specificity for their biological targets.

Q: What does "DAC" mean in CJC-1295 with DAC?

A: DAC stands for Drug Affinity Complex, a modification that causes CJC-1295 to bind to albumin in the blood, dramatically extending its half-life from minutes to days.

Q: What is acetylation?

A: The addition of an acetyl group to the N-terminus of a peptide. Acetylation is a common modification that protects the peptide from aminopeptidase degradation, potentially extending its half-life.

---

Further Reading

Now that you understand the terminology, explore the Peptides.SO Knowledge Base for detailed guides on specific peptide classes:

• •Complete Beginner Guide to Research Peptides — /articles/complete-beginner-guide-research-peptides
• •How to Choose Your First Research Peptide — /articles/how-to-choose-first-research-peptide-decision-framework
• •Research Peptide Equipment Guide — /articles/essential-peptide-research-equipment-guide-2026
• •Supplier Directory — /suppliers

> Research Disclaimer: All information in this glossary is for educational purposes only. Research peptides are not for human consumption. Always comply with applicable laws in your jurisdiction.